Abstract
Solid tumors form a permissive microenvironment with irregular features, including high pressured tumor interstitial fluid with acidic pH, co-Adaptation of cancer cells with other cells like the immune system cells, abnormal metabolism and anomalous overexpression of various pieces of molecular machinery. The functional expressions of several oncomarkers in different solid tumors have led to the development of targeted drug-delivery systems (DDSs). As a new class of DDSs, stimuli-responsive nanomedicines (SRNMs) have been developed using advanced nanobiomaterials such as biopolymers that show excellent biocompatibility with low inherent immunogenicity. In this review, we aim to overview different types of SRNMs, present deep insights into the stimuli-responsive biopolymers and discuss the most up-To-date progress in the design and development of SRNMs used as advanced DDSs for targeted therapy of cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 2171-2200 |
| Number of pages | 30 |
| Journal | Nanomedicine |
| Volume | 15 |
| Issue number | 22 |
| DOIs | |
| State | Published - Sep 2020 |
Bibliographical note
Publisher Copyright:© 2020 Future Medicine Ltd.
Funding
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
ASJC Scopus Subject Areas
- Bioengineering
- Medicine (miscellaneous)
- Biomedical Engineering
- General Materials Science
Keywords
- biopolymers
- cancer
- drug-delivery systems
- multifunctional nanomedicines
- solid tumor
- stimuli-responsive nanosystems
- targeted therapy
Disciplines
- Biomedical Engineering and Bioengineering
- Materials Science and Engineering
- Medicine and Health Sciences
Fingerprint
Dive into the research topics of 'Smart stimuli-responsive biopolymeric nanomedicines for targeted therapy of solid tumors'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS